Article Text
Echoes
IFNα combats Sjögren’s syndrome and its neuropathies
Statistics from Altmetric.com
Interferon alpha (IFNα) could become the preferred treatment for Sjögren’s syndrome (SS), with the finding from a small case study that it alleviates not only associated neuropathic symptoms but also the syndrome itself.
This is the first report of its effect against two progressive and severely disabling neuropathies …